b-Sure
PBT hold the right to a novel technology that allow first trimester screening for foetal genetic diseases, such as Down's Syndrome, using a low-risk, low-cost blood test.
Members:
Frank LandsbergerMembers:
Nora SzaszMembers:
Richard ReschenMembers:
Jim MurrayWebsite:
none
